Search papers, labs, and topics across Lattice.
The authors introduce GloPath, an entity-centric foundation model for glomerular pathology, trained on over one million glomeruli using multi-scale and multi-view self-supervised learning. GloPath was evaluated on 52 tasks across three independent cohorts, demonstrating superior performance compared to state-of-the-art methods in lesion recognition, grading, few-shot classification, and cross-modality diagnosis. Furthermore, GloPath identified statistically significant associations between glomerular morphology and clinical indicators, linking tissue-level pathology to patient outcomes.
GloPath, a new foundation model trained on over a million glomeruli, achieves state-of-the-art performance in glomerular lesion assessment and uncovers novel links between kidney morphology and patient outcomes.
Glomerular pathology is central to the diagnosis and prognosis of renal diseases, yet the heterogeneity of glomerular morphology and fine-grained lesion patterns remain challenging for current AI approaches. We present GloPath, an entity-centric foundation model trained on over one million glomeruli extracted from 14,049 renal biopsy specimens using multi-scale and multi-view self-supervised learning. GloPath addresses two major challenges in nephropathology: glomerular lesion assessment and clinicopathological insights discovery. For lesion assessment, GloPath was benchmarked across three independent cohorts on 52 tasks, including lesion recognition, grading, few-shot classification, and cross-modality diagnosis-outperforming state-of-the-art methods in 42 tasks (80.8%). In the large-scale real-world study, it achieved an ROC-AUC of 91.51% for lesion recognition, demonstrating strong robustness in routine clinical settings. For clinicopathological insights, GloPath systematically revealed statistically significant associations between glomerular morphological parameters and clinical indicators across 224 morphology-clinical variable pairs, demonstrating its capacity to connect tissue-level pathology with patient-level outcomes. Together, these results position GloPath as a scalable and interpretable platform for glomerular lesion assessment and clinicopathological discovery, representing a step toward clinically translatable AI in renal pathology.
